AzTrials
AzTrials

HealthyNCT05988762

Supramaximal Walkouts and Back Squat Performance

A study testing Supramaximal Walkout and Submaximal Walkout in people with Healthy, run by Florida State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomized, counterbalanced, crossover study is to determine the effectiveness of performing a supramaximal walkout on enhancing subsequent back squat performance in trained lifters. Read more about this study

Who is it for?
Ages 18 to 45 years, men onlyHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Supramaximal Walkout and Submaximal Walkout
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteUnited States
Study dates
1 Aug 2023to 14 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Sex: Male
  • Age: 18-45 yr
  • 1RM Back Squat ≥ 1.5x Body Weight

Who cannot join

  • Musculoskeletal injuries limiting exercise capacity
  • Cardiometabolic diseases limiting exercise capacity
  • Hasn't performed squats in the past six months
  • History of Rhabdomyolysis
  • Use of anabolic steroids in the past year

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Institute of Sports Sciences & Medicine

    Tallahassee, Florida, 32304

Other trials in United States

About this study

Official title: The Impact of Supramaximal Walkouts on Subsequent Back Squat Performance

The goal of this randomized, counterbalanced, crossover study is to determine the effectiveness of performing a supramaximal walkout on enhancing subsequent back squat performance in trained lifters. The main question we aim to answer is whether bar velocity, power output, perceived exertion, and muscle activation are altered when performing the back squat exercise after a supramaximal walkout. On the first visit, participants will be informed of the study protocols before providing oral and written informed consent. Afterwards, participants will complete maximum voluntary isometric contraction (MVIC) testing for the quadriceps and gluteus maximus muscle groups to generate a normalization for the electromyography (EMG) measurements. During the second visit, participants will perform a 1RM back squat. The third and fourth visits will be the experimental visits, where they will perform either a supramaximal (110% 1RM) or submaximal (control; 30% 1RM) walkout. A set of 1 back squat at 92.5% 1RM will be performed prior to the walkout to serve as a baseline, then 3 sets of 1 at 92.5% 1RM will be performed afterwards.

Read the detailed description

Initial Visit Participants will be asked to arrive at the Institute of Sports Sciences \& Medicine (ISSM) following a 3 h fasting period having abstained from alcohol for the previous 24 h and heavy lower body exercise for the previous 48 h. Participants will then be informed of the study protocols and procedures before providing oral and written informed consent. Following the signing of the informed consent document, participants will complete the PAR-Q+ to determine readiness for physical activity and an additional training history form to assess their previous experience with exercise and resistance training. After completion of these documents, participants' blood pressure will be assessed via an automatic blood pressure monitor (Omron, Kyoto, Japan). Next, height will be assessed to the nearest cm using a wall-mounted scale (Seca, Hamburg, Germany). Participants will then be weighed to the nearest 0.1 kg via an automated scale (Detecto® 750, Webb City, MO). Body composition will then be assessed via BodPod (Cosmed, Chicago, IL).

Following these baseline measurements, surface electromyography (EMG) will be used to assess muscle activation. EMG electrodes (Noraxon, Arizona, USA) will be placed on the gluteus maximus and vastus lateralis muscle groups of the participants' dominant side to measure electrical potentials generated. Once the electrodes are in place, participants will complete a 5-min warmup on a cycle ergometer at a self-selected easy to moderate intensity before beginning maximum voluntary contraction (MVC) testing on an isokinetic dynamometer (Biodex Multi-Joint System-PRO, Biodex Medical Systems, Inc., Shirley, NY, USA). Isometric knee extension MVC torque will be measured with the knee joint flexed. The participant will test the isometric measurement three times at submaximal levels, followed by three maximal isometric contractions. Each contraction will last for 6 s and will be followed by 30 s rest. EMG amplitudes generated during this contraction will be used for EMG normalization. Following the testing on the dynamometer, participants will complete EMG normalization testing for the gluteus maximus. To determine this, participants will lie prone on a bench with their dominant knee flexed to 90°. Manual resistance will be applied to the distal thigh as the participant is instructed to extend their hip. Similar to the dynamometer testing, the participant will complete three submaximal repetitions followed by three maximal repetitions.

Preliminary Visit For the preliminary visit, participants will arrive to the ISSM having abstained from alcohol for the previous 24 h and heavy lower body exercise for the previous 72 h. Upon arrival, EMG electrodes will be applied to the same muscle groups as the initial visit. Participants will then complete a standardized warm up consisting of 5 min on the cycle ergometer at a self-selected easy to moderate pace, followed by a battery of dynamic movements (air squats, lunges, etc.) used to prepare the participant for the back squat exercise. Following this warm-up, participants will begin the 1RM back squat testing using a modified National Strength and Conditioning Association (NSCA) protocol. A linear position transducer system (Tendo Unit, Tendo Sports Machines, London, UK) will be attached to the barbell to evaluate bar velocity during the back squat movement. Following completion of the 1RM protocol, participants will perform a 5 min active recovery (cycle ergometer).

Experimental Visits For the experimental visits, participants will arrive to the ISSM a minimum of 72 h following the previous visit and having abstained from alcohol for the previous 24 h and heavy lower body exercise for the previous 72 h. Prior to testing, the EMG electrodes will be placed on the specific muscle groups and the linear position transducer will be attached to the barbell. The participants will begin by completing the same standardized warm up from the previous visit. After the standardized warm-up, participants will begin a specific warm-up with the back squat. The participant will first complete 8 repetitions at 30% of their target load (92.5% 1RM). After a 3 min rest, the participant will complete 5 repetitions @ 50% of their target load. After another 3 min rest, the participant will complete 3 repetitions at 70% of target load followed by another 3 min rest and the final warm-up set of 1 repetition @ 85% of target load. After a 5 min rest, the participants will then complete one repetition at 92.5% 1RM. Participants will be instructed to perform this set with maximum effort. Following a 5 min rest, the participants will then perform either the supramaximal or submaximal (control) walkout. Both walkouts will consist of the participant un-racking the bar and stepping back to get set up into their starting squat position. Instead of performing the squat, the participant will remain standing in place for 10 s before returning the bar to the rack. The supramaximal walkout will be performed at 110% 1RM while the control walkout will be performed at 30% 1RM. Before this walkout set, the weight on the bar will be covered with a black trash bag to blind the participant as to which trial they are in. This will negate any anticipatory effects leading up to the walkout. Then, immediately before the participant lifts the bar off the rack, the researchers will indicate whether the weight is light or heavy to avoid issues when un-racking the bar. After the walkout, the participant will rest for 5 min, followed by 3 sets of 1 repetition at 92.5% 1RM with 5 min rest between each set. Participants will be instructed to perform these sets at maximum velocity. Following the final set, participants will perform a 5 min active recovery (cycle ergometer).

Standardization of Diet and Training Prior to each experimental trial, participants will be asked to maintain consistent nutritional (dietary and supplementation) habits for the day preceding the experimental trial and the day of the experimental trial. Additionally, participants will be asked to avoid any lower body resistance exercise for the 72 h leading up to the experimental trial. To ensure compliance, participants will be asked to complete a 48-h dietary intake form (attached) and a 72-h exercise log (attached) for the days preceding the experimental trial. Finally, participants will be asked to abstain from any alcohol for 24 h prior to the experimental trial.

Bar Velocity, Muscle Activation, and RPE Peak and mean bar velocity (m/s) and power output (W) will be assessed via a linear position transducer system (Tendo Sport Machines, Trencin, Slovakia). The transducer system will be attached to the barbell prior to the onset of the specific warm-up. The measurement will be made independently for each set and automatically converted into values of peak power output and peak velocity.

Surface electromyography (EMG) will be used to assess muscle activation during each set of back squats. EMG electrodes (Noraxon, Arizona, USA) will be placed on the vastus lateralis and gluteus maximus of the participants' dominant side after the skin is shaved, abraded, and cleaned. The electrodes will be positioned longitudinally on the belly of each muscle. Data will be collected telemetrically at 1000 Hz and subjected to full-wave rectification. Baseline maximum EMG will be assessed during the maximal isometric torque assessment of the initial visit. EMG data collected during the back squat sessions will be normalized to the baseline EMG and presented as a percentage.

Rating of perceived exertion (RPE) will be assessed using a modified Borg RPE scale (attached). The participants will be familiarized with the scale prior to beginning the 1RM protocol.

Conditions
Healthy
Being tested
Supramaximal Walkout, Submaximal Walkout
Keywords
Muscular Strength, Exercise Performance, Squat

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Supramaximal WalkoutOther

    Walkout set performed at 110% 1RM. Participant will unrack the weight, step back and brace as if to perform a back squat, hold for 10 seconds, then re-rack the weight without performing the squat.

  • Submaximal WalkoutOther

    Walkout set performed at 30% 1RM. Participant will unrack the weight, step back and brace as if to perform a back squat, hold for 10 seconds, then re-rack the weight without performing the squat.

Study groups in NCT05988762
Study groupRoleWhat they receive
Supramaximal WalkoutExperimentalWalkout set performed at 110% 1RM
Receives: Other: Supramaximal Walkout
Control (Submaximal Walkout)ExperimentalWalkout set performed at 30% 1RM
Receives: Other: Submaximal Walkout

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Back Squat Velocity

    Peak and average concentric bar velocity (m/s)

    Measured: Baseline (5 minutes before walkout) and immediately after the walkout (3 sets with 5 minutes rest in between each set)

  2. Back Squat Power Output

    Peak and average concentric power output (W)

    Measured: Baseline (5 minutes before walkout) and immediately after the walkout (3 sets with 5 minutes rest in between each set)

  3. Perceived Effort of Back Squat

    Rating of perceived exertion (RPE; 1-10)

    Measured: Baseline (5 minutes before walkout) and immediately after the walkout (3 sets with 5 minutes rest in between each set)

  4. Muscle Activation during Back Squat

    Electromyography (EMG) Amplitude

    Measured: Baseline (5 minutes before walkout) and immediately after the walkout (3 sets with 5 minutes rest in between each set)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2023
  2. Study start1 Aug 2023
  3. Primary completion1 Mar 2024
  4. Study completion14 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05988762
Sponsor's protocol ID
STUDY00004217
Status last verified
Apr 2024
First submitted
28 Jul 2023
Last updated
4 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Griest TD, McCarthy CM, Renteria LI, Paterson KGP, Eurich DF, Laskin GR, Ormsbee MJ. Supramaximal Walkouts Protect Against Performance Decrements Experienced in Repeated Sets of Back Squats. J Strength Cond Res. 2025 Jun 1;39(6):617-624. doi: 10.1519/JSC.0000000000005085. Epub 2025 Apr 23.

    PubMed 40267419

Questions about this trial

What is this clinical trial studying?

A study testing Supramaximal Walkout and Submaximal Walkout in people with Healthy, run by Florida State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Back Squat Velocity (time frame: Baseline (5 minutes before walkout) and immediately after the walkout (3 sets with 5 minutes rest in between each set)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05988762, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in